ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,309,000 | +93.2% | 60,022 | +14.7% | 0.36% | +94.7% |
| Q3 2020 | $4,300,000 | -48.5% | 52,314 | -56.0% | 0.19% | +71.6% |
| Q4 2016 | $8,356,000 | -27.8% | 118,843 | -27.2% | 0.11% | -12.8% |
| Q3 2016 | $11,580,000 | +27.3% | 163,231 | -12.2% | 0.12% | +37.4% |
| Q2 2016 | $9,098,000 | -39.2% | 186,015 | -21.2% | 0.09% | -31.6% |
| Q1 2016 | $14,954,000 | -43.5% | 236,195 | +0.1% | 0.13% | -37.3% |
| Q4 2015 | $26,476,000 | +83.0% | 236,010 | +57.1% | 0.21% | +79.7% |
| Q3 2015 | $14,469,000 | +987.9% | 150,229 | +601.1% | 0.12% | +1211.1% |
| Q1 2015 | $1,330,000 | +8.1% | 21,428 | -23.6% | 0.01% | 0.0% |
| Q4 2014 | $1,230,000 | – | 28,037 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |